ABBV vs ALTS · P/E 81, rev $16.99B vs rev $12.5M
AbbVie Inc (ABBV) versus ALT5 Sigma Corporation (ALTS) — a side-by-side from cached financials, not a winner call.
AbbVie Inc (ABBV) is a drug manufacturers - general company listed on US. It is led by Rob Michael.
ALT5 Sigma Corporation (ALTS) is a software - application company listed on NASDAQ.
Latest reported ABBV revenue for 2026-06-30 was $16.99B. Net income was $3.61B. Revenue was up 13.3% from 2026-03-31 to 2026-06-30. ABBV currently screens at market cap $334.34B and trailing P/E 80.5.
Latest reported ALTS revenue for 2024-12-28 was $12.5M. Net income was -$2.3M. ALTS currently screens at market cap $119.6M.
ABBV currently screens at market cap $334.34B and trailing P/E 80.5. ALTS currently screens at market cap $119.6M.
Not investment advice. Open the ABBV and ALTS stock pages for the full models.
Not investment advice.